News and Press Releases

Oncodesign Services extends collaboration with GIP ARRONAX to strengthen astatine-211 supply for targeted alpha radiotherapy

13 April 2026 -- Dijon, France -- Oncodesign Services has extended its collaboration with GIP ARRONAX to secure access to astatine-211 (At-211) as well as other radionuclides used in targeted...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: April 13, 2026

20 Rue Jean Mazen 21 000 Dijon France

IBSA UK&I assumes direct commercial responsibility for ialuril in the UK and Ireland

Transition supports continuity of supply and aligns ialuril with IBSA’s expanding UK uro-gynaecology portfolio 9 April 2026 -- Watford, UK -- IBSA UK&I, the UK subsidiary of Swiss pharmaceutical company...

Category: BioManufacturing, Other, Pharmaceutical
Posted: April 9, 2026

Via Pian Scairolo 49 CH-6912 Lugano-Pazzallo

Touchlight Partners with SVF Vaccines to Advance Innovative Hepatitis B/D Vaccine to Clinic

9 April 2026 -- London, UK -- Touchlight, a leading biotechnology company specialising in cell-free DNA manufacturing, is proud to announce a strategic partnership with SVF Vaccines to progress SVF’s innovative...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 9, 2026

Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

Kainova Therapeutics Expands Phase I/II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe

First patient dosed in France, expanding the DOMISOL study beyond Australia DT 7012 is being evaluated as monotherapy and in combination with pembrolizumab in a global clinical development program. 9...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 9, 2026

7171 Frederick Banting Montreal, QC H4S 1Z9 Canada

Ofichem unifies brands under single CDMO and pharmaceutical supplier

One Ofichem. One voice. A more connected approach to pharmaceutical partnerships 8 April 2026 -- Ter Apel, the Netherlands -- Ofichem has brought its brands - Ofichem BV, Ofipharma, Ofimedicine,...

Category: Drug Delivery, Logistics, Manufacturing and Packing, Other
Posted: April 8, 2026

Laboratorium Ofichem BV, Heembadweg 5, 9561 CZ Ter Apel The Netherlands

Novonesis expands global footprint with acquisition of production facility in Southeast Asia

Investment of around USD 50 million strengthens fermentation capabilities and supports the company’s long-term growth ambitions 8 April 2026 -- Copenhagen, Denmark -- Novonesis has signed an agreement with Meihua to...

Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: April 8, 2026

Biologiens Vej 2 2800 Lyngby Denmark

ESCMID Global 2026: Shionogi presents new real-world data highlighting clinical effectiveness of Fetroja/Fetcroja (cefiderocol) in MBL-producing Enterobacterales infections

Real world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 7, 2026

33 Kingsway, London, WC2B 6UF, UK

Signant Health Appoints Specialist Physician and Clinical Research Expert Dr. Graham C. Ellis as Clinical Vice President to Strengthen Metabolic Disease and Diabetes Trial Capabilities

PHILADELPHIA, PA – [April 2, 2026] – Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Dr. Graham C. Ellis as Clinical Vice...

Category:
Posted: April 7, 2026

4000 Chemical Road Suite 300 Plymouth Meeting, PA 19462

BSM Biotech Holding Launches Operations to Build Next Generation of Breakthrough Biotech Companies

Biotech venture builder focuses on identifying and developing first-in-class therapeutic innovations, exiting at IND stage 2 April 2026 -- Grainau, Germany -- BSM Biotech Holding GmbH, a newly launched biotech venture...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: April 2, 2026

Am Zigeunerbergl 3, 82491 Grainau, Germany

Plasmidsaurus Accelerates RNA-Seq: New EU Hub and Genovis Partnership Adds Stability to Speed, Without the Ice

2 April 2026 -- Cologne, Germany and California, US -- Plasmidsaurus, the leading Sequencing as a Service company, has announced two transformative evolutions of its RNA-Seq ecosystem: the launch of...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 2, 2026

Symeres and Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer

31 March 2026 -- Nijmegen, Netherlands -- Symeres, a leading CRDMO for drug discovery and development has partnered with Ambagon Therapeutics, a pre-clinical biotechnology company, to explore a new class...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: March 31, 2026

Samsung Biologics completes acquisition of GSK’s manufacturing facility in Rockville, Maryland

Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics’ geographical diversification and establishes its first U.S. manufacturing presence, expanding regional client support Plans...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: March 31, 2026

300, Songdo bio-daero, Yeonsu-gu, Incheon, Republic of Korea

Perceptive eClinical and Kayentis partnerto tackle increasing digital system complexityin global clinical trials

Nottingham, UK, and Meylan, France, March 24, 2026  – Perceptive eClinical, a trusted leader in Interactive Response Technology (IRT) solutions for global clinical trials, and Kayentis, a leading global provider of...

Category:
Posted: March 31, 2026

19 bis, chemin du vieux Chêne 38240, Meylan, France

Customised pack combines beauty and improved sustainability

Zurich, March 31, 2026 — Amcor, a global leader in developing and producing responsible packaging solutions, is supplying French hair care specialist Luxéol with a tailored version of its Prima...

Category:
Posted: March 31, 2026

Thurgauerstrasse 34 CH-8050, Zürich, Switzerland

Levicept Announces The Lancet Publication of LEVI-04 Phase II Clinical Trial Results, Showing Significant Reduction in Pain and Symptoms of Osteoarthritis

Significant improvements in pain, function and patient global outcomes demonstrated LEVI-04 well tolerated and exhibits a favourable safety profile. 30 March 2026 -- Sandwich, UK -- Levicept Ltd, a biotechnology...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 30, 2026

Innovation House Discovery Park Ramsgate Road Sandwich Kent CT13 9ND